Stuart Hughes

Stuart Hughes

Chief Executive Officer, Pathios Therapeutics

Stuart Hughes is Senior Director and Head of Pharmacology at Vertex Pharmaceuticals Europe Ltd. After obtaining a PhD in Cellular and Molecular Neuroscience from Cardiff University in 1999 he spent several years as a postdoctoral scientist studying the mechanisms that underlie a host of physiological and pathological brain rhythms. In 2006 he was awarded a Wellcome Research fellowship to continue this work before taking up a position as a group leader in CNS research at Eli Lilly and Company, pursuing a range of ion channel targets for treating a variety of neurological and psychiatric disorders. In 2013 he moved to Vertex Pharmaceuticals to lead the UK in vivo pharmacology group where his main areas of focus have been in cancer and orphan diseases. He has a particular expertise in developing translational in vivo strategies using a range of animal models and state-of-the-art biomarkers for prosecuting novel targets in immunooncolgy.